According to Genmab latest financial reports the total debt is $94.71M, an increase of 30.02% to 2022. At the end of 2022 company had $72.85M total debt. This figure represents the debts and financial obligations that Genmab combine short-term debt, long-term debt, and other fixed payment obligations (such as capital leases) of a business that are incurred while under normal operating cycles.
Year | Total debt | Change |
---|---|---|
2023 | $94.71M | 30.02% |
2022 | $72.85M | 44.08% |
2021 | $50.56M | 31.05% |
2020 | $38.58M | 78.71% |
2019 | $21.59M | - |